Federal Circuit Declines to Revisit Double-Patenting and Soda Trademark Appeals

By Editorial Team

The Federal Circuit recently made a decision not to reconsider its rulings in several intellectual property cases, including one involving Acadia Pharmaceuticals' patent related to a Parkinson's disease drug and the issue of double-patenting. Another case addressed the similarity between the "Kist" and "Sunkist" trademarks in the soft drink industry.

In the Acadia Pharmaceuticals case, the Federal Circuit upheld the patent for the Parkinson's disease drug, which also involved a discussion on double-patenting. The court's decision not to revisit this case indicates a finality to its stance on the issue.

Additionally, the Federal Circuit addressed the confusion between the "Kist" and "Sunkist" trademarks in the soft drink market. The court's ruling on this matter stands without further review.

These decisions by the Federal Circuit have significant implications for intellectual property law and trademark disputes in the pharmaceutical and beverage industries.